V. Picant

A Multimodal Framework to Guide Solid Tumor Indications for Natural Killer Cell‐Based Therapy

T cell‐based immunotherapies have achieved remarkable success in hematological malignancies but remain limited in solid tumors. Natural killer (NK) cells offer a compelling complementary approach, given their ability to recognize and kill tumor cells independently of neoantigen presentation and MHC class I expression....